T. Benjamin Dake's most recent trade in Jade Biosciences Inc was a trade of 11,454 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on July 31, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 31 Jul 2024 | 11,454 | 12,745 | - | 1.7 | 19,930 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 10,548 | 1,507 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 1,507 | 0 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 31 Jul 2024 | 1,507 | 14,252 | - | 1.7 | 2,622 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Jul 2024 | 906 | 0 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2024 | 6,853 | 95,936 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 17 Apr 2024 | 6,853 | 8,144 | - | 2.1 | 14,665 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 22.32 per share. | 17 Apr 2024 | 6,447 | 1,697 | - | 22.3 | 143,865 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 23.17 per share. | 17 Apr 2024 | 338 | 1,359 | - | 23.2 | 7,831 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 23.97 per share. | 17 Apr 2024 | 68 | 1,291 | - | 24.0 | 1,630 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2024 | 3,325 | 25,675 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 31.98 per share. | 01 Apr 2024 | 3,325 | 1,291 | - | 32.0 | 106,317 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 01 Apr 2024 | 3,325 | 4,616 | - | 10.6 | 35,278 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 27 Mar 2024 | 11,068 | 12,359 | - | 10.6 | 117,431 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 11,068 | 29,000 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 27.97 per share. | 27 Mar 2024 | 11,068 | 1,291 | - | 28.0 | 309,519 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 25 Mar 2024 | 3,432 | 4,723 | - | 10.6 | 36,414 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Mar 2024 | 3,432 | 40,068 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 28.01 per share. | 25 Mar 2024 | 3,432 | 1,291 | - | 28.0 | 96,119 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.74 per share. | 18 Mar 2024 | 27,476 | 8,872 | - | 25.7 | 707,282 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 18 Mar 2024 | 20,557 | 21,848 | - | 2.1 | 43,992 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 20,557 | 102,789 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Mar 2024 | 14,500 | 43,500 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.61 per share. | 18 Mar 2024 | 14,500 | 36,348 | - | 10.6 | 153,845 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 26.48 per share. | 18 Mar 2024 | 7,581 | 1,291 | - | 26.5 | 200,764 | Common Stock |
| Jade Biosciences Inc | T. Benjamin Dake | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2024 | 66,586 | 66,586 | - | - | Stock Options (Right to Buy) | |
| Jade Biosciences Inc | Benjamin Dake T. | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 16.11 per share. | 06 Dec 2023 | 10,283 | 1,291 | - | 16.1 | 165,628 | Common Stock |
| Jade Biosciences Inc | Benjamin Dake T. | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Dec 2023 | 7,872 | 11,574 | - | 2.1 | 16,846 | Common Stock |
| Jade Biosciences Inc | T. Benjamin Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 6,853 | 123,346 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Dec 2023 | 2,411 | 3,702 | - | 1.7 | 4,195 | Common Stock |
| Jade Biosciences Inc | Benjamin Dake T. | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 1,506 | 12,055 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin Dake T. | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 1,019 | 16,294 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Dake T. Benjamin | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Dec 2023 | 905 | 906 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 15.48 per share. | 07 Aug 2023 | 9,742 | 1,832 | - | 15.5 | 150,792 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 07 Aug 2023 | 7,871 | 11,574 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 6,853 | 150,756 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 07 Aug 2023 | 2,412 | 3,703 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,507 | 18,082 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 1,018 | 20,368 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Aug 2023 | 905 | 4,528 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 16.25 per share. | 07 Aug 2023 | 541 | 1,291 | - | 16.2 | 8,789 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 16.66 per share. | 06 Jul 2023 | 10,283 | 1,291 | - | 16.7 | 171,284 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Jul 2023 | 7,871 | 11,574 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2023 | 6,852 | 157,609 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Jul 2023 | 2,412 | 3,703 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2023 | 1,506 | 19,589 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2023 | 1,019 | 21,386 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jul 2023 | 906 | 5,433 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 16.28 per share. | 06 Jun 2023 | 10,268 | 1,306 | - | 16.3 | 167,161 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Jun 2023 | 7,871 | 11,574 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 6,853 | 164,461 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Jun 2023 | 2,412 | 3,703 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 1,507 | 21,095 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 1,018 | 22,405 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 905 | 6,339 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 17.00 per share. | 06 Jun 2023 | 15 | 1,291 | - | 17 | 255 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 21.62 per share. | 08 May 2023 | 8,685 | 2,890 | - | 21.6 | 187,805 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 08 May 2023 | 7,871 | 11,575 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 6,853 | 171,314 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 08 May 2023 | 2,413 | 3,704 | - | 1.7 | 4,199 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 22.74 per share. | 08 May 2023 | 1,599 | 1,291 | - | 22.7 | 36,355 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 1,507 | 22,602 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 1,018 | 23,423 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2023 | 906 | 7,244 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 18.17 per share. | 06 Apr 2023 | 10,283 | 0 | - | 18.2 | 186,829 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Apr 2023 | 7,871 | 10,283 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 6,852 | 178,167 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Apr 2023 | 2,412 | 2,412 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 1,507 | 24,109 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 1,019 | 24,441 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 905 | 8,150 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 23.71 per share. | 06 Mar 2023 | 10,067 | 215 | - | 23.7 | 238,687 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Mar 2023 | 7,870 | 10,282 | - | 2.1 | 16,842 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 6,852 | 185,019 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Mar 2023 | 2,412 | 2,412 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,506 | 25,616 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,018 | 25,460 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 906 | 9,055 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 24.50 per share. | 06 Mar 2023 | 215 | 0 | - | 24.5 | 5,267 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 62,000 | 62,000 | - | - | Stock Options (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 24.52 per share. | 06 Feb 2023 | 8,858 | 1,426 | - | 24.5 | 217,203 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Feb 2023 | 7,872 | 10,284 | - | 2.1 | 16,846 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 6,853 | 191,871 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Feb 2023 | 2,412 | 2,412 | - | 1.7 | 4,197 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,507 | 27,122 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 06 Feb 2023 | 1,426 | 0 | - | 25.0 | 35,679 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 1,019 | 26,478 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2023 | 905 | 9,961 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 36,570 | 198,724 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 06 Jan 2023 | 7,871 | 10,284 | - | 2.1 | 16,844 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.62 per share. | 06 Jan 2023 | 7,492 | 2,792 | - | 25.6 | 191,949 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 26.95 per share. | 06 Jan 2023 | 2,792 | 0 | - | 27.0 | 75,254 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 06 Jan 2023 | 2,413 | 2,413 | - | 1.7 | 4,199 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,507 | 28,629 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 1,018 | 27,497 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2023 | 906 | 10,866 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.14 per share. | 12 Dec 2022 | 2,059 | 2,059 | - | 2.1 | 4,406 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2022 | 2,059 | 205,577 | - | - | Stock Option (Right to Buy) | |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 28.83 per share. | 12 Dec 2022 | 1,132 | 907 | - | 28.8 | 32,632 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 30.26 per share. | 12 Dec 2022 | 907 | 0 | - | 30.3 | 27,443 | Common Stock |
| Jade Biosciences Inc | Benjamin T. Dake | SEE REMARKS | Sale of securities on an exchange or to another person at price $ 25.80 per share. | 12 Dec 2022 | 20 | 2,039 | - | 25.8 | 516 | Common Stock |